CSIMarket Company Name, Ticker, Suppliers, else..
 
Optinose Inc   (NASDAQ: OPTN)
 

Optinose Inc's Suppliers Performance

OPTN's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
OPTN Costs vs Sales of Suppliers Growth Optinose Inc recorded an increase in cost of sales by 42.16 % year on year, relative to one quarter ago cost of sales fell by -10.44 % in Q1.

• More on OPTN Suppliers



Optinose Inc recorded increase in cost of sales by 42.16 % year on year, compare to one quarter ago cost of sales fell by -10.44 % in Q1.

• More on OPTN Suppliers




Optinose Inc's Comment on Supply Chain


The company utilizes contract manufacturers (CMOs) for its production needs and does not intend to develop its own manufacturing facilities. It employs staff to oversee contract manufacturing processes and ensure compliance with regulatory requirements. The company sources XHANCE and its components from multiple third-party suppliers and manufacturing partners, including some single-source suppliers. Key supply agreements include: a supply agreement with Hovione Inter Ltd for fluticasone propionate, the active pharmaceutical ingredient in XHANCE; a manufacture and supply agreement with Contract Pharmaceuticals Limited Canada (CPL) for formulation and assembly of finished dose forms; a manufacturing services agreement with Advance Mold & Manufacturing, Inc. for liquid delivery sub-assemblies; and a manufacture and supply agreement with Hikma Pharmaceuticals USA, Inc. for finished dose forms. These agreements generally expire at the end of 2026, with provisions for earlier termination or extension. The company considers its third-party manufacturers to have sufficient capacity to meet commercial demand.

Optinose Inc's Comment on Supply Chain


The company utilizes contract manufacturers (CMOs) for its production needs and does not intend to develop its own manufacturing facilities. It employs staff to oversee contract manufacturing processes and ensure compliance with regulatory requirements. The company sources XHANCE and its components from multiple third-party suppliers and manufacturing partners, including some single-source suppliers. Key supply agreements include: a supply agreement with Hovione Inter Ltd for fluticasone propionate, the active pharmaceutical ingredient in XHANCE; a manufacture and supply agreement with Contract Pharmaceuticals Limited Canada (CPL) for formulation and assembly of finished dose forms; a manufacturing services agreement with Advance Mold & Manufacturing, Inc. for liquid delivery sub-assemblies; and a manufacture and supply agreement with Hikma Pharmaceuticals USA, Inc. for finished dose forms. These agreements generally expire at the end of 2026, with provisions for earlier termination or extension. The company considers its third-party manufacturers to have sufficient capacity to meet commercial demand.







OPTN's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Optinose Inc 112.01 90.62 -29.89 201
SUBTOTAL 0.00 0.00 0.00 -


Sources: Optinose Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Optinose Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.